Corcept Therapeutics (CORT) Leases (2019 - 2025)
Historic Leases for Corcept Therapeutics (CORT) over the last 7 years, with Q3 2025 value amounting to $4.8 million.
- Corcept Therapeutics' Leases fell 1321.1% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 1321.1%. This contributed to the annual value of $5.3 million for FY2024, which is 433666.67% up from last year.
- Corcept Therapeutics' Leases amounted to $4.8 million in Q3 2025, which was down 1321.1% from $5.0 million recorded in Q2 2025.
- In the past 5 years, Corcept Therapeutics' Leases registered a high of $5.7 million during Q2 2024, and its lowest value of $61000.0 during Q1 2024.
- Moreover, its 5-year median value for Leases was $1.7 million (2022), whereas its average is $2.4 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 8962.01% in 2023, then skyrocketed by 833770.49% in 2025.
- Over the past 5 years, Corcept Therapeutics' Leases (Quarter) stood at $514000.0 in 2021, then surged by 122.37% to $1.1 million in 2022, then tumbled by 89.5% to $120000.0 in 2023, then skyrocketed by 4336.67% to $5.3 million in 2024, then fell by 10.29% to $4.8 million in 2025.
- Its Leases was $4.8 million in Q3 2025, compared to $5.0 million in Q2 2025 and $5.1 million in Q1 2025.